CFM
MBX icon

Cornerstone Financial Management’s MBX Biosciences MBX Stock Holding History

Cornerstone Financial Management’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88K Hold
34
– – ﹤0.01% 868
2026
Q1 		$1.02K Hold
34
– – ﹤0.01% 977
2025
Q4 		$1.07K Buy
+34
New +$825 ﹤0.01% 909

Other funds holding MBX

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Polar Capital Holdings
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Cornerstone Financial Management's MBX Position: Q2 2026 in Review

Cornerstone Financial Management held its MBX Biosciences (MBX) position steady in Q2 2026 at 34 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #868.

Cornerstone Financial Management first reported a position in MBX in Q4 2025 and has held it in 3 quarters since. 172 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Cornerstone Financial Management held 34 shares of MBX Biosciences worth $1.88K as of Q2 2026.
  • Cornerstone Financial Management left its MBX Biosciences share count unchanged in Q2 2026.
  • MBX Biosciences made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #868 holding.
  • Cornerstone Financial Management first reported a position in MBX Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 172 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.